How NGS helps in the fight against drug-resistant TB

By Illumina

Tuberculosis is one of the top 10 causes of death globally, killing nearly two million people per year. Philip Supply, senior scientist at the French National Centre for Scientific Research, explains how Genoscreen is combating drug-resistant TB with Illumina’s next-generation sequencing.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.